•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
On May 12, 2025, DHG Pharmaceutical JSC (ticker DHG – HOSE) will close the shareholder list to implement the first dividend payment of 2025. According to the plan, the company will pay cash dividends at a rate of 50% (equivalent to 5,000 VND per share), with payment scheduled for May 28, 2025. With more than 130.7 million shares outstanding, DHG Pharmaceutical is expected to pay nearly 653 billion VND for this dividend. The largest shareholder is Taisho Pharmaceutical (Japan), holding over 51% of the equity, set to receive about 333 billion VND; State Capital Investment and Enterprise Management Corporation (SCIC), owning more than 43% of the shares, is expected to receive about 280 billion VND. Previously, the company approved the dividend plan for 2025 with a total cash payout ratio of 100%, equal to about 1,307 billion VND. Thus, after the 50% payout in May, the company is expected to have another 50% cash dividend around September. For 2026, DHG Pharmaceutical plans to maintain cash dividends at 7,000 VND per share, while allocating 3% of after-tax profit to the reward and welfare fund. Currently, with a market capitalization of around 13.6 trillion VND, DHG is the largest pharmaceutical company on the stock market. The company has long been known for its high and stable cash dividend policy, typically maintaining above 40% each year. In the past two years, the company has paid cash dividends at 100%. In other developments, DHG said it currently does not meet the conditions to be a public company as defined. Specifically, according to the shareholder list as of the final registration date March 23, 2026, the company has a total of 4,185 shareholders. Taisho Pharmaceutical holds 51.01% of capital, SCIC owns 43.31%, while the remaining 4,183 shareholders hold only 5.68%. With this ownership structure, the free float ratio does not meet the public company requirement. The company said it is working with the two major shareholders to devise a suitable plan to ensure compliance with current regulations.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
